Covid-19 Patients Management During Home Isolation

• Sponsor: Cairo University (Other)
• Overall Status: Active, not recruiting
• CT.gov ID: NCT04945564
• Collaborator: (none)
• Enrollment: 60
• Location: 1
• Arms: 2
• Anticipated Duration (Months): 2
• Patients Per Site Per Month: 29.5

Study Details

Study Description

Brief Summary

The study will investigate management of Covid-19 patients in home isolation.

Condition or Disease	Intervention/Treatment	Phase
Covid19	Procedure: Oxygen therapy and physical therapy; Device: Oxygen therapy	N/A

Detailed Description

A clinical trial concerned with the treatment of home isolated COVID-19 patients

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 60 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Single (Outcomes Assessor)
• Primary Purpose: Treatment
• Official Title: Covid-19 Patients Management During Home Isolation
• Actual Study Start Date: Jun 30, 2021
• Anticipated Primary Completion Date: Aug 30, 2021
• Anticipated Study Completion Date: Aug 31, 2021

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Oxygen therapy and physical therapy	Procedure: Oxygen therapy and physical therapy; Patients receive oxygen therapy and physical therapy
Active Comparator: Oxygen therapy	Device: Oxygen therapy; Patients receive oxygen therapy

Outcome Measures

Primary Outcome Measures

1. Time for recovery of pH [24 hours]

   Acidity Potential Hydrogen

2. Time for recovery of PaO2 [24 hours]

   Partial Pressure of Oxygen

3. Time for recovery of PaCO2 [24 hours]

   Partial Pressure of Carbon Dioxide

4. Chest CT scan [Baseline]

   Chest computed tomography scan

5. Chest CT scan [1 day post-treatment]

   Chest computed tomography scan

Secondary Outcome Measures

1. Time for recovery of Temperature [24 hours]

   vital sign

2. Time for recovery of Respiratory Rate [24 hours]

   vital sign

3. Time for recovery of Oxygen Saturation [24 hours]

   vital sign

4. Time for recovery of Heart Rate [24 hours]

   vital sign

5. Time for recovery of Blood Pressure [24 hours]

   vital sign

Eligibility Criteria

Criteria

• Ages Eligible for Study: 20 Years to 42 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Covid-19 patients American Society of Anesthesiologists (ASA) class I >= 21 years old <= 40 years old

Exclusion Criteria:

• Not being consistent with home-isolation regimen

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	A. Sedky	Cairo		Egypt

Sponsors and Collaborators

• Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: A. Sedky, Principal Investigator, Cairo University
• ClinicalTrials.gov Identifier: NCT04945564
• Other Study ID Numbers: REC/036-2021
• First Posted: Jun 30, 2021
• Last Update Posted: Aug 16, 2021
• Last Verified: Jun 1, 2021

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: COVID-19

Study Results

No Results Posted as of Aug 16, 2021